Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728222.2011.643299
Reference190 articles.
1. p53 in health and disease
2. T antigen is bound to a host protein in SY40-transformed cells
3. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells
4. Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
5. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Cited by 163 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. NLRC4, inflammation and colorectal cancer (Review);International Journal of Oncology;2024-09-04
2. Allicin: a promising modulator of apoptosis and survival signaling in cancer;Medical Oncology;2024-07-26
3. A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance;Frontiers in Immunology;2024-04-17
4. Comprehensive single-cell analysis reveals heterogeneity of fibroblast subpopulations in ovarian cancer tissue microenvironment;Heliyon;2024-03
5. Gene set correlation enrichment analysis for interpreting and annotating gene expression profiles;Nucleic Acids Research;2023-12-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3